CD4 and non-small cell lung carcinoma: Although no relevant preclinical studies have confirmed the effect of CAFs on the proximity of CD4+ Treg to tumor cells in locally advanced NSCLC, our study provided a new direction for targeting CAFs to improve the immunosuppressive microenvironment.